Journal of Clinical Epidemiology
Volume 50, Issue 7 , Pages 787-791 , July 1997

Decreasing Mortality from Acute Myocardial Infarctions: Effect of Attack Rates and Case Severity

  • Iqbal R Bata

      Affiliations

    • Departments of Medicine, Dalhousie University, Halifax, Nova Scotia, B3H 4H7, Canada
  • ,
  • Brian J Eastwood

      Affiliations

    • Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, B3H 4H7, Canada
  • ,
  • Ronald D Gregor

      Affiliations

    • Departments of Medicine, Dalhousie University, Halifax, Nova Scotia, B3H 4H7, Canada
  • ,
  • Judith R Guernsey

      Affiliations

    • Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, B3H 4H7, Canada
  • ,
  • Gerald A Klassen

      Affiliations

    • Departments of Medicine, Dalhousie University, Halifax, Nova Scotia, B3H 4H7, Canada
  • ,
  • B.Ross MacKenzie

      Affiliations

    • Departments of Medicine, Dalhousie University, Halifax, Nova Scotia, B3H 4H7, Canada
  • ,
  • Hermann K Wolf

      Affiliations

    • Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, B3H 4H7, Canada
    • Corresponding Author InformationHermann K. Wolf, Department of Physiology and Biophysics, Dalhousie University, Halifax NS, B3H 4H7, Canada

,Accepted 8 April 1997.

References 

  1. Uemura K, Piza Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. Wld Hlth Statist Quart. 1988;41:155–178
  2. Goldman L, Cook E. The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 1984;101:825–836
  3. Sigfusson N, Sigvaldason H, Steingrimsdottir L, et al.  Decline in ischaemic heart disease in Iceland and change in risk factor levels. Br Med J. 1991;302:1371–1375
  4. Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. Br Med J. 1994;309:23–27
  5. WHO MONICA Project Principal Investigators . The World Health Organization MONICA project (MONItoring of trends and determinants in CArdiovascular disease) (A major international collaboration). J Clin Epidemiol. 1988;41:105–114
  6. Hildebrandt P, Jensen G, Kober L, et al.  Myocardial infarction 1979–1988 in Denmark (Secular trends in age-related incidence, in-hospital mortality and complications). Eur Heart J. 1994;15:877–881
  7. Barth W, Heinemann L. Trends of acute myocardial infarction morbidity and case fatality in East Germany since 1970. Eur Heart J. 1994;15:450–453
  8. The Nova Scotia-Saskatchewan Cardiovascular Disease Epidemiology Group . Trends in incidence and mortality from acute myocardial infarction in Nova Scotia and Saskatchewan 1974 to 1985. Can J Cardiol. 1992;8:253–258
  9. Dellborg M, Eriksson P, Riha M, Swedberg K. Declining hospital mortality in acute myocardial infarction. Eur Heart J. 1994;15:5–9
  10. Gurwitz JH, Goldberg RJ, Chen Z, Gore JM, Alpert JS. Recent trends in hospital mortality of acute myocardial infarction—the Worcester Heart Attack Study. Have improvements been realized for all age groups?. Arch Intern Med. 1994;154:2202–2208
  11. Naylor CD, Chen E. Population-wide mortality trends among patients hospitalized for acute myocardial infarction (The Ontario experience, 1981 to 1991). J Am Coll Cardiol. 1994;24:1431–1438
  12. Heller RF, Dobson AJ, Alexander HM, Steele PL, Malcolm JA. Changes in drug treatment and case fatality of patients with acute myocardial infarction. Observations from the Newcastle MONICA Project, 1984/1985 to 1988/1990. Med J Aust. 1992;157:83–86
  13. WHO MONICA Project . Prepared by H. Tunstall-Pedoe KK, P. Amouyel, D. Arveiler, A.-M. Rajakangas, A. Pajak. Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Registration procedures, event rates, and case fatality in 38 populations from 21 countries in 4 continents. Circulation. 1994;90:583–612
  14. Doll R. Comparison between registries. Age-standardized rates. In:  Waterhouse J,  Muir C,  Correa P,  Powell J editor. Cancer Incidence in Five Continents, No. 15, Vol. III. Lyon: IARC Scientific Publications; 1976;p. 453–459
  15. Armitage P, Berry G. Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publications; 1987;
  16. Salomaa V, Arstila M, Kaarsalo E, et al.  Trends in the incidence of and mortality from coronary heart disease in Finland, 1983–1988. Am J Epidemiol. 1992;136:1303–1315
  17. Hosmer D, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons; 1989;48–49
  18. Armstrong P, Naylor C. Important patient subgroups. Can J Cardiol. 1993;9:497–504
  19. Lloyd BL. Declining cardiovascular disease incidence and environmental components. Aust N Z J Med. 1994;24:124–132
  20. Launbjerg J, Fruergaard P, Madsen JK, Mortensen LS, Hansen JF. Ten-year mortality of patients admitted to coronary care units with and without myocardial infarction. Risk factors from medical history and diagnosis at discharge. DAVIT-Study Group. Danish Verapamil Infarction Trial. Cardiology. 1994;85:259–266
  21. Sprafka JM, Burke GL, Folsom AR, McGovern PG, Hahn LP. Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival. The Minnesota Heart Survey. Diabetes Care. 1991;14:537–543
  22. Nidorf S, Parsons R, Thompson P, Jamrozik K, Hobbs M. Reduced risk of death at 28 days in patients taking beta blocker before admission to hospital with myocardial infarction. Br Med J. 1990;300:71–74
  23. Klein HH, Hengstenberg C, Peuckert M, Jurgensen R. Comparison of death rates from acute myocardial infarction in a single hospital in two different periods (1977–1978 versus 1988–1989). Am J Cardiol. 1993;71:518–523

PII: S0895-4356(97)00067-X

Journal of Clinical Epidemiology
Volume 50, Issue 7 , Pages 787-791 , July 1997